Robert Hill is Chief Executive Officer, with a deep background in technical and clinical development of radiation oncology systems.
Prior to joining TAE Life Sciences, he was Senior Vice President of Corporate Development at Accuray Incorporated; Senior Vice President of R&D; and the company’s Chief Product Officer. During his tenure at Accuray, he was responsible for product strategy, innovation, and design and development. Rob was also responsible for mergers, acquisitions, partnerships and intellectual property development.
He previously served as Vice President of Engineering at North American Scientific; and held various R&D leadership and software development roles at NOMOS Corporation, where he was an early innovator in the fields of Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGRT), serial tomotherapy, and Monte Carlo dose calculation.
Rob earned a Bachelor of Science degree in Computer Engineering from Carnegie Mellon University.